Investigation of the relationship between eye involvement and systemic diseases in patients with COVID-19

Investigation of whether there is a relationship between eye involvement and systemic diseases in patients diagnosed with Coronavirus Disease-2019 (COVID-19). One hundred and tenpatients who admitted to our hospital and were diagnosed with COVID-19 by Polymerase Chain Reaction (PCR) and chest computed tomography (CT) were included in the study. The demographic characteristics and existing systemic diseases of the patients were questioned. Whether the patients had ocular involvement associated with COVID-19 was investigated. The patients with eye involvement were examined in terms of systemic diseases and the drugs they used. Sixty oneof the patients were male and 49 were female. Eight (7.3%) of the 110 patients had ocular involvement. Six of these 8 patients had no comorbid diseases. Two patients with additional systemic disease had a common diagnosis of chronic kidney disease. The mean age of those with ocular involvement (44.88 ± 21.97 years) was lower than the average age of the total group (52.29 ± 22.93 years). The most common additional systemic disease in patients with COVID-19 was hypertension (26.4%).All patients had conjunctival hyperemia. Five of the patients had epiphora, 5 had secretion, 4 had burning-stinging and 2 had ocular pain.3 of the patients were smokers.In 2 patients, the first finding of COVID-19 started with eye complaints.One of the patients with ocular involvement had a history of previous Fuchs uveitis. Although eye involvement in COVID-19 patients is not common, it may appear as the first finding. Detection of patients with eye involvement may be beneficial in terms of early diagnosis, treatment and prevent transmission. In addition, the relationship between comorbid diseases and eye involvement may be important in terms of prognosis.

PDF

___

1. Gavriatopoulou M, Korompoki E, Fotiou D, et al. Organ-specific manifestations of COVID-19 infection. Clin Experimental Med. 2020:1-14.

2. Son M,Friedman K. Coronavirus disease 2019 (COVID-19): Multisystem inflammatory syndrome in children. Up to Date. 2020.

3. Temgoua MN, Endomba FT, Nkeck JR, et al. Coronavirus disease 2019 (COVID-19) as a multi-systemic disease and its impact in low-and middleincome countries (LMICs). SN Comprehensive Clin Med. 2020:1-11.

4. Liu H, Chen S, Liu M, et al. Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and meta-analysis. Aging Disease. 2020;11:668.

5. Sanyaolu A, Okorie C, Marinkovic A, et al. Comorbidity and its Impact on Patients with COVID-19. SN Comprehensive Clin Med. 2020:1-8.

6. Garg S. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 States, March 1–30, 2020. MMWR. Morbidity Mortality Weekly Report. 2020;69.

7. Singh AK, Gupta R, Ghosh A, et al. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes & Metabolic Syndrome: Clin Res Rev. 2020.

8. Zhao Q, Meng M, Kumar R, et al. The impact of COPD and smoking history on the severity of COVID‐19: a systemic review and meta‐analysis. J Medical Virolog. 2020.

9. Yoldas MA,Yoldas H. Pediatric COVID-19 disease: a review of the recent literature. Pediatric Annals. 2020;49:319-25.

10. Seah I,Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocular Immunol Inflammation. 2020;28:391-5.

11. Bettach E, Zadok D, Weill Y, et al. Bilateral anterior uveitis as a part of a multisystem inflammatory syndrome secondary to COVID‐19 infection. J Med virolog. 2020.

12. Zago Filho LA, Lima LH, Melo GB, et al. Vitritis and outer retinal abnormalities in a patient with COVID-19. Ocular Immunol Inflammation. 2020;28:1298-300.

13. Zhou Y, Duan C, Zeng Y, et al. Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients. Ophthalmology. 2020;127:982-3.

14. Shemer A, Einan-Lifshitz A, Itah A, et al. Ocular involvement in coronavirus disease 2019 (COVID-19): a clinical and molecular analysis. Intern Ophthalmol. 2020:1-8.

15. Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA ophthalmology. 2020;138:575-8.

16. Loon S, Teoh S, Oon L, et al. The severe acute respiratory syndrome coronavirus in tears. British journal of ophthalmology. 2004;88:861-3.

17. Guo D, Xia J, Shen Y, et al. SARS‐CoV‐2 may be related to conjunctivitis but not necessarily spread through the conjunctiva SARS‐CoV‐2 and conjunctiva. J Medical Virology. 2020.

18. Öncül H, Öncül FY, Alakus MF, et al. Ocular findings in patients with coronavirus disease 2019 (COVID‐19) in an outbreak hospital. J Medical Virolog. 2020.

19. Atum M, Boz AAE, Çakır B, et al. Evaluation of conjunctival swab PCR results in patients with SARS-CoV-2 infection. Ocular Immunol Inflammation. 2020;28:745-8.

20. Shaigany S, Gnirke M, Guttmann A, et al. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19. Lancet. 2020;396:8-10.

21. Zheng Y-Y, Ma Y-T, Zhang J-Y, et al. COVID-19 and the cardiovascular system. Nature Reviews Cardiol. 2020;17:259-60.

22. Mi J, Zhong W, Huang C, et al. Gender, age and comorbidities as the main prognostic factors in patients with COVID-19 pneumonia. Am J Translational Res. 2020;12:6537.

23. Cure E,Cure MC. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic. Diabetes & Metabolic Syndrome: Clin Res Reviews. 2020.

24. Yang L, Liu S, Liu J, et al. COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduction and Targeted Therapy. 2020;5:1- 8. 25. Cao X. COVID-19: immunopathology and its implications for therapy. Nature Reviews Immunol. 2020;20:269-70.

26. Wang X, Fang X, Cai Z, et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and meta-analysis. Research. 2020;2020:2402961.

27. Fang X, Li S, Yu H, et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging (Albany NY). 2020;12:12493.